Litigation Details for CELGENE CORPORATION v. SUN PHARMACEUTICAL INDUSTRIES, INC. (D.N.J. 2018)
✉ Email this page to a colleague
CELGENE CORPORATION v. SUN PHARMACEUTICAL INDUSTRIES, INC. (D.N.J. 2018)
Docket | ⤷ Try a Trial | Date Filed | 2018-07-13 |
Court | District Court, D. New Jersey | Date Terminated | |
Cause | 15:1126 Patent Infringement | Assigned To | Susan Davis Wigenton |
Jury Demand | None | Referred To | Leda Dunn Wettre |
Patents | 7,465,800; 7,855,217; 7,968,569 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in CELGENE CORPORATION v. SUN PHARMACEUTICAL INDUSTRIES, INC.
Details for CELGENE CORPORATION v. SUN PHARMACEUTICAL INDUSTRIES, INC. (D.N.J. 2018)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2018-07-13 | 1 | Complaint | United States Patent Nos. 7,465,800 (“the ʼ800 patent”); 7,855,217 (“the ʼ217 patent”); and 7,968,569… 1. This is an action for patent infringement under the patent laws of the United States, 35 U.S.C…7,968,569 (“the ʼ569 patent”), all owned by Celgene (collectively, “the patents-in-suit”). … of the ’800 patent, constitutes infringement of one or more of the claims of that patent under 35 U.S.C… of the ’217 patent, constitutes infringement of one or more of the claims of that patent under 35 U.S.C | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |